Name: Galectin Therapeutics Inc. (GALT) Balance Sheet
Creator: FinSpry

Galectin Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Galectin Therapeutics Inc. (GALT) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	15.12	25.66	18.59	39.65	27.14	47.48	8.25
Cash & Short-Term Investments	15.12	25.66	18.59	39.65	27.14	47.48	8.25
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.13	0.43	1.96	2.17	2.32	0.00	0.00
Total Current Assets	17.25	27.71	20.55	41.82	29.47	48.21	8.83
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.05	0.09	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.24	0.49	0.73	0.01	0.14	0.26	0.17
Total Non-Current Assets	0.24	0.49	0.73	0.01	0.00	0.26	0.17
Total Assets	17.50	28.20	21.29	41.83	29.60	48.47	9.01
Current Liabilities
Accounts Payable	5.66	15.68	3.89	1.81	1.29	1.73	0.81
Short-Term Debt	21.14	0.00	0.00	0.00	0.00	0.00	0.00
Current Portion of Long-Term Debt	21.12	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	6.66	9.14	8.05	6.43	4.00	0.00	0.00
Other Current Liabilities	8.62	1.13	0.97	0.07	0.07	1.09	0.00
Total Current Liabilities	35.41	15.68	13.01	9.03	5.40	2.82	2.11
Non-Current Liabilities
Long-Term Debt	85.11	71.74	39.83	29.05	0.00	0.00	0.00
Other Non-Current Liabilities	0.05	0.02	0.07	1.13	0.00	0.05	0.00
Total Non-Current Liabilities	85.16	33.65	40.47	30.18	0.00	1.78	0.00
Total Liabilities	120.57	88.44	53.48	39.21	5.41	4.60	2.11
Stockholders' Equity
Common Stock	0.06	0.06	0.06	0.06	0.06	0.00	0.00
Retained Earnings	-401.57	-354.37	-309.57	-270.69	-240.00	-216.39	-196.22
Additional Paid-in Capital	296.22	291.85	275.08	271.00	0.00	259.67	194.13
Shares Outstanding	63.16	61.85	59.43	59.34	0.00	0.00	0.00
Total Stockholders' Equity	-103.07	-61.96	-32.19	2.62	24.19	43.87	6.90
Total Liabilities & Equity	17.50	28.20	21.29	41.83	0.00	48.47	9.01